News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
Inventors at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have developed a new potential therapy for mild cognitive impairment (MCI), a stage prior to Alzheimer’s disease (AD), that has the potential to halt the progression from MCI to AD. Alzheimer’s
Rare Disease Day is taking place on February 28 th! While it is a worldwide event, each year the National Center for Advancing Translational Sciences (NCATS) and the NIH Clinical Center sponsor the day at NIH. The purpose of Rare Disease Day is to raise awareness about rare diseases, the people they
There is a significant, unmet medical need for male contraceptive options. Inventors at the National Institute of Child Health and Human Development (NICHD) are seeking collaborators for a potential non-hormonal male contraceptive that could fill this need. This contraceptive works by using cyclic